Headaches
10
1
2
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
10.0%
1 terminated out of 10 trials
87.5%
+1.0% vs benchmark
20%
2 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (10)
MyVitalC: Sleep and Everyday Headache Management
ATI Evidence-based Guide Investigating Clinical Services
RCT Evaluating Intranasal Fentanyl in the Pain Management of Children With Headaches
Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura
Telemedicine Versus Traditional Specialist Consultation for Headache: a Non-inferiority Trial
Stress Management for Chronic Headaches
Study of Loestrin 24(24 Days of "Real" Pills) Fe Versus Loestrin 1/20 (21 "Real" Pills)
Nasal Carbon Dioxide (CO2)for the Treatment of Temporomandibular Disorders (TMD)Related Pain
Tailored Internet Information Supply for Patients - Part 2
Women's Use of Alternative Medicine: A Multiethnic Study